MedAvant Among InfoWorld's Top 100 Companies for IT Solutions

Business Wire, Nov 15, 2006

Annual Awards Honor Most Creative and Cutting-Edge Implementations of Enterprise Technology

ATLANTA -- MedAvant Healthcare Solutions (MedAvant) (NASDAQ:PILL), a leader in healthcare technology and transaction services, today announced its inclusion in IDG's InfoWorld 100 awards for IT projects that demonstrate the most creative use of cutting-edge technologies to further their business goals.

Nominations were submitted by InfoWorld readers, technology partners, and end-user companies in late-summer. To be considered, projects must stretch beyond the typical, off-the-shelf solution, and must use multiple technologies in innovative ways to serve well-defined business goals.

MedAvant was recognized for the methods and tools it uses to ensure security and protect confidential information from being sent outside the company. The project included new systems by PortAuthority, a new Class A data center, and new WAN circuits from Verizon Business Services.

"We are very pleased to receive this award in recognition of the many ways we control and protect our confidential information," said Rob Mims, Vice President of Security and Network Engineering for MedAvant. "The PortAuthority system detects and blocks confidential information that is not encrypted from being distributed electronically outside our company. The new data center will enhance our ability to process around the clock, even if disaster strikes. Together with the new WAN circuits, these steps provide state-of-the-art protection for the personal health information our customers entrust to us."

Award winners were formally announced November 13 in the print edition of InfoWorld as well as online.

"It's been said that fortune favors the bold. The inspiration for this year's finalists to tackle such sweeping changes varies widely Co from reducing delivery time of products and services to replacing cumbersome legacy systems," said Richard Gincel, InfoWorld Senior Editor. "But regardless of the motivation, high ambition unites them all."

About MedAvant Healthcare Solutions

MedAvant, a leader in healthcare technology services, provides healthcare transaction processing, medical cost containment services through NPPN[TM], business process outsourcing solutions and related value-added products to physicians, payers, pharmacies, medical laboratories, and other healthcare suppliers. To facilitate these services, MedAvant operates Phoenix(SM), a highly scalable and secure national information platform, which supports real-time direct connectivity and transaction processing between healthcare clients. For more information about MedAvant, please visit the Company's website at http://www.medavanthealth.com. MedAvant is a trade name of ProxyMed, Inc.

About IDG

International Data Group (IDG) is the world's leading technology media, events, and research company. IDG publishes more than 300 magazines and newspapers in 85 countries including CIO, CSO, Computerworld, GamePro, InfoWorld, Macworld, Network World, and PC World. IDG's online network includes more than 400 Web sites spanning business technology, consumer technology, digital entertainment, and gaming worldwide. IDG is a leading producer of more than 170 technology-related events including LinuxWorld Conference & Expo, Macworld Conference & Expo, DEMO, and IDC Directions. IDC, a subsidiary of IDG, is the premier global provider of market intelligence, advisory services, and events. Over 850 IDC analysts in 50 countries provide global, regional, and local expertise on technology and industry opportunities and trends. Additional information about IDG, a privately company, is available at www.idg.com.

Forward Looking Statement

Statements in this release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. In some cases, forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. Actual results could differ materially from projected results because of factors such as: the soundness of our business strategies relative to the perceived market opportunities; MedAvant's ability to successfully develop, market, sell, cross-sell, install and upgrade its clinical and financial transaction services and applications to current and new physicians, payers, medical laboratories and pharmacies; the ability to compete effectively on price and support services; MedAvant's ability and that of its business associates to perform satisfactorily under the terms of its contractual obligations, and to comply with various government rules regarding healthcare and patient privacy; entry into markets with vigorous competition, market acceptance of existing products and services, changes in licensing programs, product price discounts, delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels; the availability of competitive products or services; the continued ability to protect the company's intellectual property rights, implementation of operating cost structures that align with revenue growth; uninsured losses; adverse results in legal disputes resulting in liabilities; unanticipated tax liabilities; the effects of a natural disaster or other catastrophic event beyond our control that results in the destruction or disruption of any of our critical business or information technology systems. Any of these factors could cause the actual results to differ materially from the guidance given at this time. For further cautions about the risks of investing in MedAvant, we refer you to the documents MedAvant files from time to time with the Securities and Exchange Commission, including, without limitation, its most recently filed Quarterly Report on Form 10-Q and its Annual Report on Form 10-K/A. MedAvant does not assume, and expressly disclaims, any obligation to update information contained in this document. Although this release may remain available on our website or elsewhere, its continued availability does not indicate that we are reaffirming or confirming any of the information contained herein.